Install Free Gold Price Widget!
Install Free Gold Price Widget!
Install Free Gold Price Widget!
|
- Dupilumab: Uses, Dosage, Side Effects, Warnings - Drugs. com
Dupilumab injection is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic rhinosinusitis with nasal polyps, COPD with an eosinophilic phenotype, eosinophilic esophagitis (EOE), chronic spontaneous urticaria, or prurigo nodularis The brand name is Dupixent Dupilumab can be self-administered subcutaneously every 1 to 4 weeks, depending on the condition
- Dupixent: Uses, Dosage, Side Effects, Warnings - Drugs. com
Dupixent (generic name: dupilumab) can start to work in 2 to 4 weeks to relieve symptoms associated with inflammatory conditions like eczema, asthma, and sinus swelling due to nasal polyps Initial improvements in some patients were seen at 12 weeks for chronic obstructive pulmonary disease (COPD), prurigo nodularis, and chronic spontaneous
- Dupilumab Side Effects: Common, Severe, Long Term - Drugs. com
For healthcare professionals Applies to dupilumab: subcutaneous solution General adverse events The most common adverse reactions were injection site reactions (which included erythema, edema, pruritus, pain, and swelling), conjunctivitis, allergic conjunctivitis, arthralgia, oral herpes, and eosinophilia
- Dupilumab Información Española De la Droga - Drugs. com
Dupilumab también se utiliza en adultos con otros medicamentos para el tratamiento de mantenimiento de la enfermedad pulmonar obstructiva crónica (EPOC; COPD, por sus siglas en inglés) que no ha sido controlada con otros medicamentos Dupilumab no es un medicamento de rescate para tratar problemas respiratorios que empeoran rápidamente
- Dupilumab Dosage Guide + Max Dose, Adjustments - Drugs. com
Detailed Dupilumab dosage information for adults and children Includes dosages for Asthma, Sinusitis, Atopic Dermatitis and more; plus renal, liver and dialysis adjustments
- Dupilumab Monograph for Professionals - Drugs. com
Dupilumab did not alter immune response to tetanus antigen; immune responses to diphtheria and pertussis antigens not assessed Vaccines, live Not known if administration of live vaccines during dupilumab treatment will impact safety or effectiveness of these vaccines Do not use in patients receiving dupilumab Warfarin
- Dupixent (dupilumab) FDA Approval History - Drugs. com
Dupixent (dupilumab) is an interleukin-4 receptor alpha antagonist used for the treatment of atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, prurigo nodularis, chronic obstructive pulmonary disease (COPD), and chronic spontaneous urticaria
- Dupilumab - brand name list from Drugs. com
Dupilumab (Ingredient) Drugbank ID: DB12159 The information below refers to products available in the United States that contain dupilumab Products containing dupilumab dupilumab systemic Brand name: Dupixent Drug class: interleukin inhibitors Dupilumab systemic is used in the treatment of: Asthma; Asthma, Maintenance; Atopic Dermatitis
|
|
|